2024-02-11 00:21:26
In France, the debate around cannabidiol (CBD), one of the compounds in the cannabis plant, has been heated.important legislative developments recently.
Indeed, France’s position on cannabis as a psychoactive substance has traditionally been restrictive. In recent years, however, the perception of this plant has begun to change.
In this article, we will shed light on the current situation of French legislation regarding CBD.
What is CBD?
CBD is a chemical compound naturally present in the cannabis plant. Unlike THC (tetrahydrocannabinol), which is the other major component of cannabis and known for its psychoactive effects, CBD does not cause a state of euphoria or “high”.
CBD interacts with the human body’s endocannabinoid system, which plays a crucial role in regulating functions such as sleep, appetite, pain, and immune response. These interactions can contribute to benefits such as reducing anxiety, stress, chronic pain and may even have anti-inflammatory and neuroprotective effects.
A signal of openness and progress
Due to the potential therapeutic properties of this plant, in 2019the French government launched a experimental medical cannabis programmarking an important step towards its acceptance as a therapeutic tool and allowing patients with specific pathologies to access cannabis-based treatments.
But it’s only December 2022 that France has gone further by approving the consumption and sale of CBD flowers for recreational purposes. While cannabis remains only authorized for medical purposes, cannabis “light”that is to say a version with low THC content (less than 0.2%) and rich in CBD, finally became legal for everyone.
This decision comes after the French government in December 2021 limited the cultivation of hemp to fibers and seeds for the exclusive manufacture of CBD-based products. But the Council of State then judged this ban “disproportionate” and recognized that the sale of hemp flowers and leaves does not compromise the fight against narcotics. On the contrary, the Legalization stimulates an increasingly growing economic sector.
Furthermore, in November 2020, the European Court of Justice also declared that CBD products are not considered narcotics and can be marketed freely in the European Union.
Conclusion
The legalization of “light” cannabis in France is a sign of openness and progress for these European countries which do not yet authorize the production and sale of CBD. Revising the legislation helped stimulate research into the beneficial effects of cannabis and boost the country’s economy.
Indeed, this decision paved the way for an emerging market for CBD products and legal cannabis varieties, offering French consumers a wide range of options for well-being and relaxation. Among them, the variety Red Poison stands out for its exceptional quality and unique composition which offers a unique relaxation experience.